HEG1 and mesothelioma: We have shown in the previous study that the anti-HEG1 mAb SKM9-2 recognizes the glycopeptide sequence and can detect mesothelioma more specifically (99%) and sensitively (92%) than other mAbs against current mesothelioma markers.